Traditional Chinese medicine for treating coronary sclerotic plaque

Abstract

The invention relates to a traditional Chinese medicine for treating coronary sclerotic plaque. The traditional Chinese medicine for treating the coronary sclerotic plaque can effectively solve the problems of relatively high surgical risk of existing coronary sclerotic plaque treatment, requirement for combined use of western medicines during traditional Chinese medicine treatment, high dose, liable drug resistance after being taken for a long time as well as poor curative effect. The traditional Chinese medicine is prepared from the following raw materials by weight: astragalus membranaceus, ginseng, raw bighead atractylodes rhizome, trichosanthes kirilowii maxim, wine-processed allium macrostemon, rhizoma pinellinae praeparata, fried immature bitter orange, salvia miltiorrhiza, safflower, kudzu vine root, scorpion powder, centipede powder, pseudo-ginseng powder, leech powder, gadfly powder, amber powder, silky ant powder, dragon's blood powder, vinegar-processed turtle shell, ground beetle, peach kernel, frankincense, myrrh and earthworm. The traditional Chinese medicine is prepared as concentrated water-bindered pills according to a conventional method. The traditional Chinese medicine can be used for treating coronary plaque and stenosis by adopting methods for invigorating qi, activating blood circulation, resolving phlegm and removing blood stasis; and moreover, the traditional Chinese medicine can obviously improve or eliminate clinical symptoms, reverse plaque, increase myocardial blood and oxygen supply as well as improve myocardial cell metabolic capability so as to fundamentally achieve the purpose of correcting myocardial ischemia and hypoxia. In addition, the traditional Chinese medicine is safe and reliable to use.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a traditional Chinese medicine (also known as Guanmai Huichun Pill) for treating coronary artery sclerosis plaque. Background technique [0002] Coronary atherosclerosis plaque refers to the plaque formed by lipid and complex carbohydrate accumulation, fibrous tissue hyperplasia and calcium deposition on the coronary intima. Controlling the formation and progression of coronary atherosclerotic plaques is the key link in the treatment of coronary heart disease. Western medicine mainly includes interventional surgery, coronary artery bypass grafting and statin drugs in terms of treatment. The risk of intervention and bypass surgery is relatively high, and restenosis is easy in the stent and bridge after surgery. Traditional Chinese medicine can play a role through multiple channels, multiple links, multiple points, and multiple levels. Although there are traditional Chinese medicines for ...

AI Technical Summary

Problems solved by technology

[0003] In view of the above situation, in order to overcome the defects of the prior art, the object of the present invention is to provide a traditional Chinese medicine for treating coronary atherosclerotic plaque, which can effectively solve the problem that the surgical risk of existing coronary atherosclerotic plaque is relatively high, and Chinese medicine treatment needs to cooperate with western medicine. , taking a large amount, long-term use leads to drug resistance and poor curative effect

Images